"2246"^^ . "V tabulce 1 resp. v tabulce 2 je uveden v\u00FDpo\u010Det standardn\u00ED a sn\u00ED\u017Een\u00E9 d\u00E1vky, kter\u00FD vych\u00E1z\u00ED z plochy povrchu t\u011Bla, p\u0159i \u00FAvodn\u00EDch d\u00E1vk\u00E1ch p\u0159\u00EDpravku Capecitabin Actavis 1250 mg/m2 a 1000 mg/m2. \nDoporu\u010Den\u00E9 d\u00E1vkov\u00E1n\u00ED (viz bod 5.1): \nMonoterapie \nKarcinom tlust\u00E9ho st\u0159eva, kolorekta a karcinom prsu \nP\u0159i samostatn\u00E9m pod\u00E1v\u00E1n\u00ED p\u0159\u00EDpravku Capecitabin Actavis v adjuvantn\u00ED l\u00E9\u010Db\u011B karcinomu tlust\u00E9ho st\u0159eva, v l\u00E9\u010Db\u011B metastatick\u00E9ho kolorekt\u00E1ln\u00EDho karcinomu nebo lok\u00E1ln\u011B pokro\u010Dil\u00E9ho nebo metastatick\u00E9ho karcinomu prsu je doporu\u010Dena \u00FAvodn\u00ED d\u00E1vka 1250 mg/m2 u\u017E\u00EDvan\u00E1 dvakr\u00E1t denn\u011B (r\u00E1no a ve\u010Der; to odpov\u00EDd\u00E1 celkov\u00E9 denn\u00ED d\u00E1vce 2500 mg/m2) po dobu 14 dn\u016F s n\u00E1sleduj\u00EDc\u00ED 7denn\u00ED p\u0159est\u00E1vkou bez pod\u00E1v\u00E1n\u00ED p\u0159\u00EDpravku."@cs . "4"^^ . . . . . . . . . . . . . . "2937"^^ . .